Consistent with the data found in the literature, the totality of our available data indicates that changes in DNMT and TET transcript levels, especially DNMT3A and DNMT3B, trigger DNA damage, accelerate cellular aging, and lead to de novo methylation profile changes in AD. This evidence concerns the gene DNMT3A and Alzheimer disease.